Physician profile
Jenifer E Jones
NPI 1588698088
$560.63
in general payments reported to CMS, 2019-2025
15 companies · $251 in 2025
The $251 reported for 2025 was more than what 80% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.68 · 2021: $82.95 · 2022: $137 · 2023: $23.12 · 2024: $50.09 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $127.75 | 2025 | |
| Merck Sharp & Dohme LLC | $114.73 | 2021-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Organon LLC | $112.78 | 2021-2023 | Nexplanon |
| Boston Scientific Corporation | $38.83 | 2025 | Intracept |
| Alexion Pharmaceuticals, INC. | $20.02 | 2025 | Strensiq |
| Dexcom, INC. | $17.02 | 2022 | |
| Sanofi Pasteur INC. | $16.94 | 2022 | |
| Acadia Pharmaceuticals INC | $16.68 | 2020 | |
| Collegium Pharmaceutical, INC. | $16.54 | 2025 | Jornay Pm |
| Bayer Healthcare Pharmaceuticals INC. | $14.40 | 2025 | |
| Lilly USA, LLC | $14.16 | 2022 | |
| Phathom Pharmaceuticals, INC. | $13.11 | 2024 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $12.87 | 2022 | |
| Janssen Biotech, INC. | $12.72 | 2022 | |
| Glaxosmithkline, LLC. | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenifer Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.